Mortality within the longest · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in all‐cause mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in cardiovascular mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Prolonged hospitalization (> 1 week) · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment efficacy for depression (long term: 24 months) · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment efficacy for depression (long term: 24 months) compared with any comparator (moderate certainty).
1 finding from 1 review
Improvement in depression symptoms (long term: 5 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Intervention not reported
Mortality at longest · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
It is very uncertain whether the intervention changes mortality at longest (very low certainty).
1 finding from 1 review
Assessment of long‐term morbidity · women at increased risk of low birthweight babies (maternal outcomes)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Long‐term mortalityc · children and adults with sepsis
Corticosteroids showed no clear difference in long‐term mortalityc compared with placebo or usual care (low certainty).
1 finding from 1 review
Number of participants with adverse events ‐ superinfection (up to longest · children and adults with sepsis
Corticosteroids showed no clear difference in number of participants with adverse events ‐ superinfection (up to… compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Number of participants with adverse events ‐ muscle weakness (up to longest · children and adults with sepsis
Corticosteroids leads to higher number of participants with adverse events ‐ muscle weakness (up to… compared with placebo or usual care (high certainty).
1 finding from 1 review
Intervention not reported
Smoking abstinence at longest · People who smoke or who have recently quit
The intervention showed no clear difference in smoking abstinence at longest (low certainty).
1 finding from 1 review
Intervention not reported
Relapse prevention at longest · People who smoke or who have recently quit
It is very uncertain whether the intervention changes relapse prevention at longest (very low certainty).
1 finding from 1 review
Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participants with serious adverse reactions · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Physical functioning End of treatment and long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression Long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found